Jazz Pharmaceuticals PLC (JAZZ)
109.29
+2.19
(+2.04%)
USD |
NASDAQ |
Apr 18, 16:00
109.29
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Enterprise Value: 10.76B for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 10.76B |
| April 16, 2024 | 10.88B |
| April 15, 2024 | 11.00B |
| April 12, 2024 | 10.98B |
| April 11, 2024 | 11.16B |
| April 10, 2024 | 11.20B |
| April 09, 2024 | 11.19B |
| April 08, 2024 | 11.26B |
| April 05, 2024 | 11.34B |
| April 04, 2024 | 11.27B |
| April 03, 2024 | 11.38B |
| April 02, 2024 | 11.42B |
| April 01, 2024 | 11.50B |
| March 28, 2024 | 11.59B |
| March 27, 2024 | 11.60B |
| March 26, 2024 | 11.44B |
| March 25, 2024 | 11.62B |
| March 22, 2024 | 11.68B |
| March 21, 2024 | 11.82B |
| March 20, 2024 | 11.87B |
| March 19, 2024 | 11.88B |
| March 18, 2024 | 11.78B |
| March 15, 2024 | 11.62B |
| March 14, 2024 | 11.46B |
| March 13, 2024 | 11.43B |
| Date | Value |
|---|---|
| March 12, 2024 | 11.31B |
| March 11, 2024 | 11.36B |
| March 08, 2024 | 11.41B |
| March 07, 2024 | 11.34B |
| March 06, 2024 | 11.39B |
| March 05, 2024 | 11.47B |
| March 04, 2024 | 11.41B |
| March 01, 2024 | 11.50B |
| February 29, 2024 | 11.50B |
| February 28, 2024 | 12.17B |
| February 27, 2024 | 12.33B |
| February 26, 2024 | 12.36B |
| February 23, 2024 | 12.33B |
| February 22, 2024 | 12.09B |
| February 21, 2024 | 12.09B |
| February 20, 2024 | 11.95B |
| February 16, 2024 | 11.98B |
| February 15, 2024 | 11.98B |
| February 14, 2024 | 11.70B |
| February 13, 2024 | 11.67B |
| February 12, 2024 | 11.82B |
| February 09, 2024 | 11.77B |
| February 08, 2024 | 11.72B |
| February 07, 2024 | 11.74B |
| February 06, 2024 | 11.85B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.455B
Minimum
Mar 23 2020
17.14B
Maximum
Jul 12 2021
11.30B
Average
11.79B
Median
Dec 06 2023
Enterprise Value Benchmarks
| Alkermes PLC | 3.530B |
| Endo International PLC | -777.78M |
| Medtronic PLC | 122.01B |
| Perrigo Co PLC | 7.393B |
| Iterum Therapeutics PLC | 19.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 94.15M |
| Revenue (Quarterly) | 1.012B |
| Total Expenses (Quarterly) | 871.44M |
| EPS Diluted (Quarterly) | 1.42 |
| Gross Profit Margin (Quarterly) | 89.40% |
| Profit Margin (Quarterly) | 9.30% |
| Earnings Yield | 5.60% |
| Operating Earnings Yield | 7.59% |
| Normalized Earnings Yield | 5.705 |